Skip to content

Insider · CIK 0002013987

Nathan L. Mata

officer

Files at BLTE (BELITE BIO, INC). First filing Apr 16, 2026, latest May 8, 2026.

Nathan L. Mata files SEC Form 4 as officer at BLTE (BELITE BIO, INC). Since Apr 16, 2026, Nathan L. Mata has reported 0 open-market buys worth $0 and 17 open-market sells worth $2.7M, the latest filed on May 8, 2026.

A track record needs three past buys with six months of prices behind them; Nathan L. Mata has 0, so none is measured yet.

The newest scored trade: sold $102k of BLTE on May 7, 2026, filed May 8, 2026, scored 25 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 17 sells worth $2.7M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 17
$0 bought, $2.7M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BLTE: BELITE BIO, INC

BLTEOct 9, 2026 · close 154.49

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
25Weak
BLTEsell10b5-1
BELITE BIO, INC
$102k
666 shares
-100%+175% from low-18% from high
26Weak
BLTEsell10b5-1
BELITE BIO, INC
$154k
1,000 shares
-60%+175% from low-18% from high
16Weak
BLTEsell10b5-1
BELITE BIO, INC
$156k
1,000 shares
-38%+172% from low-19% from high
16Weak
BLTEsell10b5-1
BELITE BIO, INC
$156k
1,000 shares
-27%+172% from low-19% from high
11Weak
BLTEsell10b5-1
BELITE BIO, INC
$156k
1,000 shares
-21%+173% from low-19% from high
11Weak
BLTEsell10b5-1
BELITE BIO, INC
$157k
1,000 shares
-18%+180% from low-16% from high
11Weak
BLTEsell10b5-1
BELITE BIO, INC
$156k
1,000 shares
-15%+172% from low-19% from high
11Weak
BLTEsell10b5-1
BELITE BIO, INC
$159k
1,000 shares
-13%+179% from low-17% from high
11Weak
BLTEsell10b5-1
BELITE BIO, INC
$163k
1,000 shares
-12%+187% from low-14% from high
11Weak
BLTEsell10b5-1
BELITE BIO, INC
$160k
1,000 shares
-10%+184% from low-15% from high
21Weak
BLTEsell 410b5-1
BELITE BIO, INC
$166k
1,000 shares
-9%+189% from low-14% from high
21Weak
BLTEsell 410b5-1
BELITE BIO, INC
$170k
1,000 shares
-9%+195% from low-12% from high
21Weak
BLTEsell 410b5-1
BELITE BIO, INC
$166k
1,000 shares
-8%+202% from low-13% from high
21Weak
BLTEsell 410b5-1
BELITE BIO, INC
$164k
1,000 shares
-7%+202% from low-13% from high
21Weak
BLTEsell 410b5-1
BELITE BIO, INC
$160k
1,000 shares
-6%+189% from low-17% from high
21Weak
BLTEsell 410b5-1
BELITE BIO, INC
$162k
1,000 shares
-7%+203% from low-13% from high
21Weak
BLTEsell 410b5-1
BELITE BIO, INC
$168k
1,000 shares
-6%+209% from low-11% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Apr 15, 2026 BLTE
Belite Bio, Inc.
16,666
0.04% of outstanding
$2.9MApr 15, 2026none
Aug 21, 2025 BLTE
Belite Bio, Inc.
30,000
0.09% of outstanding
$1.9MAug 21, 2025none
Mar 19, 2025 BLTE
Belite Bio, Inc
30,166
0.09% of outstanding
$2.0MMar 19, 2025none
Nov 19, 2024 BLTE
Belite Bio, Inc
30,000
0.10% of outstanding
$2.5MNov 19, 2024$1.4M

Transactions

The newest 50 of 104 rows this insider has filed.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 7, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-226$152.45$34k440May 8, 2026
May 7, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-428$153.56$66k12May 8, 2026
May 7, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-3$154.61$4649May 8, 2026
May 7, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-9$155.25$1,3970May 8, 2026
May 6, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-8$151.57$1,2131,658May 7, 2026
May 6, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-424$152.67$65k1,234May 7, 2026
May 6, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-128$153.42$20k1,106May 7, 2026
May 6, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-240$154.41$37k866May 7, 2026
May 6, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-100$155.97$16k766May 7, 2026
May 6, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-100$156.00$16k666May 7, 2026
May 5, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-120$153.92$18k2,546May 6, 2026
May 5, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-363$154.44$56k2,183May 6, 2026
May 5, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-173$155.48$27k2,010May 6, 2026
May 5, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-121$156.53$19k1,889May 6, 2026
May 5, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-155$157.29$24k1,734May 6, 2026
May 5, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-68$158.11$11k1,666May 6, 2026
May 4, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-32$153.50$4,9123,634May 5, 2026
May 4, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-236$154.24$36k3,398May 5, 2026
May 4, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-325$155.21$50k3,073May 5, 2026
May 4, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-235$156.57$37k2,838May 5, 2026
May 4, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-172$157.49$27k2,666May 5, 2026
May 1, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-52$153.89$8,0034,614May 4, 2026
May 1, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-288$154.38$44k4,326May 4, 2026
May 1, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-346$155.48$54k3,980May 4, 2026
May 1, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-82$156.24$13k3,898May 4, 2026
May 1, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-106$157.45$17k3,792May 4, 2026
May 1, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-65$158.35$10k3,727May 4, 2026
May 1, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-38$159.08$6,0453,689May 4, 2026
May 1, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-23$160.00$3,6803,666May 4, 2026
Apr 30, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-42$155.68$6,5385,624May 1, 2026
Apr 30, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-517$156.59$81k5,107May 1, 2026
Apr 30, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-340$157.37$54k4,767May 1, 2026
Apr 30, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-101$158.15$16k4,666May 1, 2026
Apr 29, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-278$154.58$43k6,388Apr 30, 2026
Apr 29, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-259$155.52$40k6,129Apr 30, 2026
Apr 29, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-339$156.43$53k5,790Apr 30, 2026
Apr 29, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-102$157.39$16k5,688Apr 30, 2026
Apr 29, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-22$158.19$3,4805,666Apr 30, 2026
Apr 28, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-12$154.65$1,8567,654Apr 29, 2026
Apr 28, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-8$155.36$1,2437,646Apr 29, 2026
Apr 28, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-53$156.61$8,3007,593Apr 29, 2026
Apr 28, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-222$157.49$35k7,371Apr 29, 2026
Apr 28, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-62$158.71$9,8407,309Apr 29, 2026
Apr 28, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-380$159.42$61k6,929Apr 29, 2026
Apr 28, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-120$160.27$19k6,809Apr 29, 2026
Apr 28, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-89$161.72$14k6,720Apr 29, 2026
Apr 28, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-54$162.14$8,7566,666Apr 29, 2026
Apr 27, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-44$160.83$7,0778,622Apr 28, 2026
Apr 27, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-280$161.62$45k8,342Apr 28, 2026
Apr 27, 2026BLTE
BELITE BIO, INC
SOpen-market sale
American depositary share10b5-1
-231$162.38$38k8,111Apr 28, 2026
50 of 104 rows shown.

Questions about Nathan L. Mata

Answered from the filings on this page, as of the latest one.

Is Nathan L. Mata buying or selling?

In the last 12 months Nathan L. Mata reported 0 open-market buys worth $0 and 17 open-market sells worth $2.7M on SEC Form 4; the latest was sold $102k of BLTE on May 7, 2026. Grants, option exercises and tax withholding are not counted.

How did Nathan L. Mata's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nathan L. Mata has 0.

Where does Nathan L. Mata file Form 4?

Nathan L. Mata has filed Form 4 at BLTE (BELITE BIO, INC) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.